Previous 10 | Next 10 |
Galera Therapeutics (NASDAQ:GRTX) +15%. Splunk (NASDAQ:SPLK) +7%. Digital World Acquisition (NASDAQ:DWAC) +6%. Momentus (NASDAQ:MNTS) +6%. Cabaletta Bio (NASDAQ:CABA) +6%. Aspen (NASDAQ:ASPU) -21%. Communications Systems (NASDAQ:JCS) -11%. DAVIDsTEA (NASDAQ:DTEA) -6%. BioNTech SE (NASDAQ:BNTX...
3 Penny Stocks to Add to Your Watchlist Right Now Investing in penny stocks is and has been very popular for the past few years. And as a result of the extraordinary times we’re living in, trading penny stocks in 2021 is extremely volatile. So whether you’re new to buy...
Gainers: Galera Therapeutics (NASDAQ:GRTX) +106%. Nuverra Environmental Solutions (NYSE:NES) +33%. CPS Technologies (NASDAQ:CPSH) +24%. Terminix (NYSE:TMX) +21%. Alzamend Neuro (NASDAQ:ALZN) +17%. MIND Technology (NASDAQ:MIND) +17%. Landec Corporation (NASDAQ:LNDC) +13%. Soliton (NASDAQ:SOLY)...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lion Electric (NYSE: LEV ) stock was charging higher on Tuesday morning after the electric vehicle (EV) company revealed a new order contract. Source: Shutterstock Langs Bus Lines is the company behind this or...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galera Therapeutics (NASDAQ: GRTX ) stock is rocketing higher on Tuesday after the cancer treatment company revealed corrected results from a Phase 3 clinical trial. Source: Bukhta Yurii / Shutterstock.com Acc...
Gainers: Galera Therapeutics (NASDAQ:GRTX) +116%, Alzamend Neuro (NASDAQ:ALZN) +18%, Soliton (NASDAQ:SOLY) +12%, Kiromic BioPharma (NASDAQ:KRBP) +6%, Biofrontera (NASDAQ:BFRI) +5%. Losers: Adagio Therapeutics (NASDAQ:ADGI) -78%, Adagio Th...
Galera Therapeutics (NASDAQ:GRTX) jumps 103.6% premarket after corrected results from Phase 3 ROMAN trial of avasopasem for the treatment of RT-induced severe oral mucositis (SOM) in patients with head and neck cancer (HNC) achieved statistical significance on the primary endpoint. ...
Galera Therapeutics (NASDAQ:GRTX) +138% announces primary endpoint met statistical significance in corrected topline efficacy data of phase 3 ROMAN trial of avasopasem. Nuverra Environmental Solutions (NYSE:NES) +33%. Terminix Global Holdings (NYSE:TMX) +25%. MIND Technology (NASDAQ:MIND...
Corrected topline Phase 3 ROMAN data demonstrate primary endpoint achieved statistical significance in reducing the incidence of radiotherapy-induced severe oral mucositis (p=0.045) Topline results from single-arm Phase 2a trial of avasopasem in Europe in line with the ROMAN tri...
MALVERN, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today ann...
News, Short Squeeze, Breakout and More Instantly...
Galera Therapeutics Inc. Company Name:
GRTX Stock Symbol:
NYSE Market:
Galera Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Nauticus Robotics Inc. (KITT) rose 29.5% to $0.1787 on volume of 92,016,620 shares Freight Technologies Inc. (FRGT) rose 92.0% to $1.2 on volume of 65,878,105 shares Aethlon Medical Inc. (AEMD) rose 68.2% to $0.7379 on volume of 48,98...
A look at the top 10 most actives in the United States ENDRA Life Sciences Inc. (NDRA) rose 88.2% to $0.159999 on volume of 216,555,450 shares Crown Electrokinetics Corp. (CRKN) fell 13.1% to $0.0908 on volume of 52,298,971 shares Actelis Networks Inc (ASNS) rose 591.5% to $3.25 on volume...
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...